Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib

Sorafenib is an oral anti-angiogenic multi-kinase inhibitor used for systemic therapy in patients with advanced hepatocellular carcinoma (HCC) who are not suitable candidates for surgery or liver transplantation. An earlier study conducted with HCC tumor tissue suggested that ERK phosphorylation (pE...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Kalathil, Suresh Gopi, Lugade, Amit Anand, Iyer, Renuka, Miller, Austin, Thanavala, Yasmin
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2016
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087301/
https://ncbi.nlm.nih.gov/pubmed/27853648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1226718
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires